Are Monind Ltd latest results good or bad?

2 hours ago
share
Share Via
Monind Ltd's latest results are poor, reporting a net loss of ₹0.69 crores in Q2 FY26 and no revenue for over seven quarters, indicating significant financial distress and operational challenges. The company faces mounting losses and a precarious liquidity position, with liabilities far exceeding assets.
Monind Ltd's latest financial results reflect a challenging operational landscape. The company reported a net loss of ₹0.69 crores in Q2 FY26, which is a slight deterioration compared to the previous quarter's loss of ₹0.73 crores. Notably, Monind has not generated any revenue for at least seven consecutive quarters, indicating a complete cessation of business operations. This lack of sales has contributed to cumulative losses of ₹1.42 crores for the first half of FY26, compared to ₹1.27 crores in the same period the previous year.
The interest burden remains a significant concern, with expenses rising to ₹0.63 crores in Q2 FY26, marking a 12.50% increase year-on-year. This escalation occurs despite the absence of any revenue-generating activities, suggesting either rising debt levels or increased borrowing costs. The company's book value stands at a negative ₹371.36, further underscoring its financial distress and technical insolvency, as liabilities exceed assets substantially. In terms of operational metrics, the data indicates that Monind's interest expenses have remained constant, while operating losses have slightly worsened. The company's balance sheet shows a precarious liquidity position, with current assets of only ₹0.06 crores against current liabilities of ₹53.49 crores, resulting in a current ratio of 0.001x. This indicates severe working capital stress. Overall, Monind Ltd's financial results highlight a company in significant distress, with no operational activities and mounting losses driven primarily by interest expenses. The company has seen an adjustment in its evaluation, reflecting its ongoing challenges and lack of viable pathways for recovery.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News